We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTE icon
551
DTE Energy
DTE
$28.6B
$23.5M 0.02%
204,057
+13,194
+7% +$1.7M
CHE icon
552
Chemed
CHE
$7.02B
$23.5M 0.02%
53,728
+36,618
+214% +$17.6M
KMF
553
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$23.4M 0.02%
3,303,063
-9,179
-0.3% -$74.7K
WPC icon
554
W.P. Carey
WPC
$15.9B
$23.3M 0.02%
340,689
-22,739
-6% -$1.86M
AWK icon
555
American Water Works
AWK
$27B
$23.3M 0.02%
178,773
+1,253
+0.7% +$189K
XYZ
556
Block Inc
XYZ
$47.5B
$23.2M 0.02%
422,712
-35,171
-8% -$2.49M
USFD icon
557
US Foods
USFD
$24.3B
$23.2M 0.02%
877,984
+121,153
+16% +$3.76M
VNLA icon
558
Janus Henderson Short Duration Income ETF
VNLA
$3.35B
$23.2M 0.02%
478,194
-372,605
-44% -$18.1M
IYH icon
559
iShares US Healthcare ETF
IYH
$3.76B
$23.2M 0.02%
457,765
+33,115
+8% +$1.79M
PTC icon
560
PTC
PTC
$16.3B
$23.1M 0.02%
221,196
-1,867
-0.8% -$213K
VGSH icon
561
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
$23.1M 0.02%
400,241
-1,510
-0.4% -$88.4K
EIX icon
562
Edison International
EIX
$26.9B
$23.1M 0.02%
408,628
-26,652
-6% -$1.76M
MMP
563
DELISTED
Magellan Midstream Partners, L.P.
MMP
$23.1M 0.02%
486,499
+3,285
+0.7% +$165K
GDX icon
564
VanEck Gold Miners ETF
GDX
$27.5B
$23M 0.02%
954,276
-27,745
-3% -$702K
XBI icon
565
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$23M 0.02%
289,857
+29,748
+11% +$2.51M
MKL icon
566
Markel Group
MKL
$22.8B
$23M 0.02%
21,195
+2,022
+11% +$2.47M
EXPD icon
567
Expeditors International
EXPD
$23B
$22.9M 0.02%
259,695
+1,684
+0.7% +$169K
MUB icon
568
iShares National Muni Bond ETF
MUB
$45.8B
$22.8M 0.02%
222,616
+36,300
+19% +$3.86M
BAB icon
569
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$22.8M 0.02%
889,048
+63,527
+8% +$1.74M
ULTA icon
570
Ulta Beauty
ULTA
$23.3B
$22.8M 0.02%
56,753
+8,904
+19% +$3.59M
SSNC icon
571
SS&C Technologies
SSNC
$18.7B
$22.7M 0.02%
475,555
+65,061
+16% +$3.75M
FXO icon
572
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$22.7M 0.02%
616,689
-10,937
-2% -$446K
CAH icon
573
Cardinal Health
CAH
$56.3B
$22.7M 0.02%
339,711
+51,400
+18% +$3.26M
DOX icon
574
Amdocs
DOX
$6.1B
$22.6M 0.02%
285,039
-26,161
-8% -$2.22M
AVY icon
575
Avery Dennison
AVY
$13.6B
$22.6M 0.02%
139,000
-4,714
-3% -$855K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.